|
CN112209814A
|
|
Novel method for synthesizing vitamin K2
|
|
CN110698467A
|
|
Synthetic method of engagliflozin
|
|
CN110452228A
|
|
The preparation method of high-purity triphenyl Olmesartan ethyl ester
|
|
CN110483317A
|
|
The preparation method and application of high-purity 3- isobutylglutaric acid dimethyl ester
|
|
CN109942446A
|
|
A kind of preparation method of Pregabalin
|
|
CN109651078A
|
|
A kind of preparation method of the anti-form-1-of high-purity (the fluoro- 4- propylcyclohexyl of 2,2- bis-)-4- propylbenzene
|
|
CN109081812A
|
|
4- (1- hydroxyl -1- Methylethyl) -2- propyl imidazole -5- carboxylic acid, ethyl ester monohydrate
|
|
CN104356069A
|
|
Preparation method and application of high-purity olmesartan medoxomil intermediate ethyl 4-(1-hydroxy-1-methylethyl)-2-propylimidazolyl-5-carboxylate
|
|
CN104262260A
|
|
Preparation method and application high-purity olmesartan medoxomil intermediate 2-propylimidazolyl-4,5-dicarboxylic acid
|
|
CN103588786A
|
|
Purification method of faropenem sodium hydrate
|
|
CN103588756A
|
|
Preparation method of trityl olmesartan
|
|
CN103275074A
|
|
Olmesartan derivative and preparation method thereof
|
|
CN103254188A
|
|
Azilsartan derivative and preparation method thereof
|
|
CN103145688A
|
|
Preparation method of 4, 5-dichloromethyl-1, 3-dioxacyclopentene-2-one
|
